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ABSTRACT This systematic review aimed to systematise the different designs used to deliver pulmonary
rehabilitation during acute exacerbations of COPD (AECOPD) and explore which ones are the most
effective. PubMed, Scopus, Web of Science, EBSCO and Cochrane were searched. Randomised controlled
trials comparing pulmonary rehabilitation or at least one of its components with usual care or comparing
different components of pulmonary rehabilitation were included. Network meta-analysis was conducted in
MetaXL 5.3 using a generalised pairwise modelling framework. Pooled effects compared each treatment to
usual care.
42 studies were included. Most studies were conducted in an inpatient setting (57%) and started the
intervention 24–48 h after hospital admission (24%). Exercise training (71%), education and psychosocial
support (57%) and breathing techniques (55%) were the most used components. Studies combining
exercise with breathing techniques presented the larger effects on exercise capacity (weighted mean
difference (WMD) −41.06, 95% CI −131.70–49.58) and health-related quality of life (WMD 16.07, 95% CI
10.29–21.84), and breathing techniques presented the larger effects on dyspnoea (WMD 1.90, 95% CI
0.53–3.27) and length of hospitalisation (effect size =0.15, 95% CI −0.28–0.57). A few minor adverse
events were found.
Pulmonary rehabilitation is a safe intervention during AECOPD. Exercise, breathing techniques, and
education and psychosocial support seem to be the core components for implementing pulmonary
rehabilitation during AECOPD. Studies may now focus on comparisons of optimal timings to start the
intervention, total duration of the intervention, duration and frequency of sessions, and intensity for
exercise prescription.
Introduction
COPD is a progressive disease that is often punctuated by exacerbations, defined as episodes of acute
worsening of respiratory symptoms that result in additional therapy [1, 2]. Acute exacerbations of COPD
(AECOPD) impact negatively on patients’ health status and disease progression, and increase patients’
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susceptibility to more exacerbations, hospitalisations and death [1, 2]. Treatment goals for patients with
AECOPD are, therefore, to minimise the negative impact of these events and prevent their recurrence [1].
Pulmonary rehabilitation is a comprehensive intervention presenting well-established benefits in patients
with stable COPD [1, 3]. It has been shown to: 1) improve exercise capacity, muscle strength, functional
capacity and health-related quality of life (HRQoL); 2) reduce symptoms, hospitalisations and unscheduled
healthcare visits; and 3) enhance self-management and self-efficacy [3]. Given these benefits, it would
seem reasonable to consider pulmonary rehabilitation as a management strategy for AECOPD [4].
However, studies assessing the role of pulmonary rehabilitation during AECOPD have shown inconsistent
results [1, 2, 5, 6]. One of the reasons for this inconsistency is the heterogeneity in the design of
pulmonary rehabilitation programmes. Studies have been delivering pulmonary rehabilitation programmes
in diverse settings (i.e. inpatient, outpatient, community, home), with different components implemented
in isolation or in combination (e.g. aerobic training, muscle strengthening, education) and with a wide
variety of durations, intensities and timings (i.e. the time chosen to integrate patients into the pulmonary
rehabilitation programme) [5]. It is known that all these aspects may influence efficacy of pulmonary
rehabilitation [5]. Thus, this systematic review aimed to systematise the different designs used to deliver
pulmonary rehabilitation during AECOPD and explore which ones are the most effective.
Methods
Search strategy
Searches in the Cochrane Library and the International Prospective Register of Systematic Reviews
(PROSPERO) were conducted prior to the development of the present systematic review to exclude the
existence of reviews or protocols with the same purpose as the present one. Since no similar studies were
found, the systematic review protocol was registered at PROSPERO (www.crd.york.ac.uk/prospero
registration no. CRD42017056930).
A systematic literature search was performed in February 2017 on the following electronic databases:
PubMed, Scopus, Web of Science, EBSCO and Cochrane. Additionally, weekly automatic updates retrieved
from the databases were performed until March 2020. Search terms were based on a combination of the
following keywords: (“acute exacerbation of chronic obstructive pulmonary disease” OR “AECOPD” OR
“acute exacerbation of COPD” OR “exacerbation of COPD”) AND (“pulmonary rehabilitation” OR
“respiratory rehabilitation” OR “physiotherapy” OR “physical therapy” OR “respiratory physiotherapy” OR
“respiratory physical therapy” OR “exercise” OR “exercise training” OR “breathing exercise” OR “breathing
technique” OR “airway clearance” OR “walking” OR “aerobic training” OR “resistance training” OR
“balance training” OR “flexibility training” OR “stretch training” OR “strength training” OR “education”
OR “psychoeducation” OR “psychosocial support”). The search was limited to terms found in titles,
abstracts and keywords. Additionally, the reference lists of the selected articles and key systematic reviews
were scanned for other potential eligible studies.
Eligibility criteria and study selection
Studies were included if they: 1) studied patients within 3 weeks of AECOPD onset [1, 4, 7] or until
2 weeks after discharge [8]; 2) used pulmonary rehabilitation or at least one of its components (i.e. any
kind of exercise training, breathing techniques, airway clearance techniques or education and psychosocial
support) as an intervention; 3) were written in English, French, Portuguese or Spanish; and 4) were
randomised controlled trials. Studies were admissible independently of the treatment setting or degree of
severity of the AECOPD. Randomised controlled trials comparing pulmonary rehabilitation or at least one
of its components with usual care or comparing different components of pulmonary rehabilitation were
considered. Abstracts in conference proceedings were excluded. After removing duplicates, two reviewers
assessed all the potential studies identified. Studies were selected based on their titles and abstracts; when
the title and abstract were relevant to the purpose of the review, the full-text article was read carefully to
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decide on its inclusion. A third reviewer was consulted to solve any disagreements. This systematic review
was reported according to the Preferred Reporting Items for Systematic reviews and Meta-analyses
(PRISMA) guidelines [9].
Quality assessment and data extraction
Two reviewers independently assessed the quality of the included studies with the Delphi List, a list
composed of nine items [10]. The total score consists of summing the number of items that are satisfied
(i.e. evaluated as yes) and ranges from 0 to 9 [11]. Studies with a total score ⩾5 were considered to be of
high quality [11, 12].
Data from the included studies were extracted to a structured table format comprising the following topics:
study (first author, year of publication, country); population (number of participants, age, sex, forced
expiratory volume in 1 s (FEV1)); timing and setting; type of intervention; duration of the intervention and
intensity of each of its components; duration and frequency of sessions; outcomes and outcome measures;
and results. All noninvasive outcome measures (e.g. no blood analysis or biopsies) were considered.
Corresponding authors of the included studies were contacted via e-mail to request additional information
about the interventions and/or data (e.g. means and standard deviations) when required. All data were
retrieved from the published articles, supplementary files and authors’ contacts.
Data analysis and synthesis
Inter-rater agreement analysis using Cohen’s kappa was used to explore the consistency of the quality
assessment performed by the two reviewers. The value of Cohen’s kappa ranges from 0 to 1 and can be
interpreted as slight (⩽0.2), fair (0.21–0.4), moderate (0.41–0.6), substantial (0.61–0.8), or almost perfect
(⩾0.81) agreement [13]. The statistical analysis was performed using IBM SPSS 24.0.
Studies were grouped accordingly to the component (i.e. exercise training, education and psychosocial
support, breathing techniques) or a combination of components used in their intervention. Only studies
that included at least exercise training and education and psychosocial support [4] were considered to have
performed pulmonary rehabilitation. Due to the large diversity of outcome measures and units of
measurement used, and the wide variety of interventions implemented, it was only possible to conduct
network meta-analysis with a limited number of variables, and comparisons were only possible between
components and duration of the interventions. Intervention programmes were considered to be either
short-term programmes, when the total duration of their intervention was <8 weeks, or long-term
programmes, if the intervention lasted ⩾8 weeks [4]. Only studies performing more than one session in
their interventions were considered in the network meta-analysis. For comparisons between components
of the intervention, studies that performed at least exercise (i.e. exercise training or pulmonary
rehabilitation) were considered in the same subgroup. For variables that did not fit in the network
meta-analysis, effect sizes (ES) were computed whenever possible. Individual ES were calculated as Cohens’
d based on the pre/post-means and standard deviations, according to the formula of MORRIS [14], and
were interpreted as small (⩾0.2), medium (⩾0.5) or large (⩾0.8) [15]. Network meta-analysis was
conducted using MetaXL 5.3, which implements the generalised pairwise modelling framework for
meta-analysis [16]. This method involves: 1) pooling effect sizes for direct comparisons between each
combination of two interventions using meta-analysis; 2) performing indirect comparisons by automated
generation of all possible closed loops of three treatments of which one is common to two studies; and 3)
pooling direct and indirect effects using meta-analysis to give a final effect size comparing each treatment
to the common comparator, i.e. control (standard of care) [16]. Pooled effect estimates were calculated
assuming a random-effects model. Input data for the 6-min walk test (6MWT), the modified Borg scale
and the St George’s respiratory questionnaire (SGRQ) were the standardised mean difference in each
group and the respective standard deviation, either directly retrieved from the study or estimated [17].
Output data were the weighted mean difference (WMD) and corresponding confidence intervals.
Regarding the length of hospitalisation, input data were the mean and standard deviation of each study,
and output data were the pooled Cohen’s d value and corresponding confidence intervals. Statistical
heterogeneity across pooled direct effects was assessed using Cochran’s Q and the H index. Transitivity
was assessed by examining inconsistency across the network using the weighted pooled H index, with
values <3 being considered to indicate minimal inconsistency [16].
Results
Study selection and quality assessment
The literature search provided a total of 6029 records. After removal of duplicates, 5484 records were
screened for relevant content using titles and abstracts. From these, 5396 were excluded. The full-text of 88
potentially relevant articles was assessed and 64 articles were excluded due to the following reasons: 1) studies
were not randomised controlled trials (n=24); 2) articles were written in German (n=3) or Italian (n=1);
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3) were abstracts only (n=9); 4) studies did not include pulmonary rehabilitation or any of its components as
an intervention (n=8); 5) studies did not include participants with AECOPD (n=3) or presented the results
for this population independently (n=2); and 6) studies did not include participants within 3 weeks of the
AECOPD onset or until 2 weeks after discharge (n=14). An additional 18 studies were retrieved from the
search for relevant articles within the reference lists (n=10) and the weekly automatic updates (n=8). Thus, a
total of 42 studies were included in this review and 25 were used for meta-analysis (figure 1).
Results of the methodological quality assessment are presented in table 1. Most of the studies (n=33;
78.6%) were high quality. The agreement between the two reviewers was substantial (k=0.80 (95% CI 0.64–
0.97), p<0.001; percentage of agreement 85.3%).
Study characteristics
Characteristics of the included studies are shown in table S1 and Appendix 1. The 42 studies included
were conducted in 19 different countries. Almost 50% of the studies were published in the past 5 years. Six
(14.2%) of the included studies were multicentre [18–23].
Records identified through 
database searching
(n=6029)
Additional records identified 
through other sources
(n=18)
Records after duplicates removed
(n=5484)
Records excluded based





Not a randomised controlled trial (n=24)
Did not include participants within 3 
weeks of the AECOPD onset or until 2 
weeks after discharge (n=14)
Abstracts in conference proceedings (n=9)
Did not include PR or any of its 
components as intervention (n=8)
Written in German or Italian (n=4)
Did not include participants with AECOPD 



























Studies included in qualitative synthesis
(n=42)
Studies included in quantitative
synthesis (meta-analysis)
(n=25)
FIGURE 1 PRISMA flowchart of the included studies. AECOPD: acute exacerbation of COPD; PR: pulmonary
rehabilitation.
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TABLE 1 Quality assessment of the included studies with the Delphi List

















KIRSTEN [32] Yes Don’t know Yes Yes Don’t know No No Yes No 4/9
NAVA [37] Yes Don’t know Yes Yes Don’t know Don’t know Don’t know Yes No 4/9
BELLONE [54] Yes No Yes Yes Don’t know Don’t know Don’t know Yes No 4/9
HERNANDEZ [56] Yes No Yes Yes Don’t know Don’t know Yes Yes No 5/9
YOHANNES [52] Yes Don’t know Yes Yes Yes Yes Yes Yes No 7/9
MAN [35] Yes Don’t know Yes Yes No No No Yes Yes 5/9
MURPHY [36] Yes Yes Yes Yes Don’t know Don’t know No Yes No 5/9
CASAS [19] Yes No No Yes Don’t know Don’t know Yes Yes Yes 5/9
GARCIA-AYMERICH [47] Yes No Yes Yes Don’t know No Yes Yes No 5/9
EATON [29] Yes Yes Yes Yes Yes No No Yes Yes 7/9
KODRIC [48] Yes Don’t know Don’t know Yes Don’t know Don’t know Don’t know Yes No 3/9
BABU [25] Yes Don’t know No Yes No No Yes Yes No 4/9
SEYMOUR [38] Yes Yes Yes Yes No Don’t know No Yes Yes 6/9
TROOSTERS [43] Yes Yes Yes Yes No No No Yes No 5/9
KO [33] Yes Don’t know Yes Yes Yes No No Yes Yes 6/9
CROSS 2012 [20] Yes Yes Yes Yes Don’t know Don’t know No Yes Yes 6/9
PUHAN [23] Yes Yes Yes Yes Don’t know Don’t know Don’t know Yes Yes 6/9
TANG [40] Yes Don’t know Yes Yes Yes No Don’t know Yes Yes 6/9
CHAPLIN [27] Yes Don’t know Ye Yes No No Yes Yes No 5/9
LAINSCAK [57] Yes Yes Yes Yes No No No Yes No 6/9
ALI [24] Yes Don’t know Yes Yes Don’t know No No Yes No 4/9
BORGES [26] Yes Yes Yes Yes Yes No No Yes No 6/9
DEEPAK [28] Yes No Yes Yes Don’t know Don’t know Don’t know Yes No 4/9
GREULICH [30] Yes Yes Yes Yes Yes Yes Don’t know Yes No 7/9
OSADNIK [22] Yes Yes Yes Yes Yes No No Yes No 6/9
SONG [39] Yes Don’t know Yes Yes No No Yes Yes No 5/9
VALENZA [55] Yes Don’t know Yes Yes Don’t know No Don’t know Yes Yes 5/9
HE [31] Yes Don’t know No Yes Don’t know Don’t know Don’t know Yes No 3/9
LIAO [34] Yes Don’t know Yes Yes Yes No No Yes No 5/9
BENZO [18] Yes No Yes Yes Yes No Don’t know Yes Yes 6/9
EASTWOOD [49] Yes Don’t know Yes Yes Yes No No Yes No 5/9
JOHNSON-WARRINGTON
[21]
Yes Yes Yes Yes Yes No No Yes Yes 7/9
TORRES-SÁNCHEZ [42] Yes Don’t know Yes Yes Yes No No Yes No 5/9
BASRI [50] Yes No No Yes Yes No Yes No No 4/9
TORRES -SÁNCHEZ [41] Yes Yes Yes Yes Yes No Don’t know Yes No 6/9
ABOUMATAR [58] Yes No Yes Yes Yes No No Yes Yes 6/9
JANAUDIS-FERREIRA [59] Yes Don’t know Yes Yes Yes No No Yes No 5/9
Lopez-LOPEZ [53] Yes Yes Yes Yes Don’t know No No Yes No 5/9
TORRES-SÁNCHEZ [51] Yes Yes Yes Yes Don’t know No No Yes No 5/9
LOPEZ-LOPEZ [46] Yes Yes Yes Yes Yes No No Yes Yes 7/9
LOPEZ-LOPEZ [45] Yes Yes Yes Yes Yes No No Yes No 6/9


















In total, 3569 patients with a mean age of 69.1 years and a mean FEV1 of 39.4% predicted (data gathered
from 35 studies, as seven of the included studies did not report the mean FEV1 % pred) were enrolled in
the included studies.
Studies evaluated the effect of the applied intervention on patients’ exercise capacity (n=23, ES range −1.8–
5.0) [21, 22, 24–44], muscle strength (n=11, ES −0.5–1.5) [26, 27, 36–38, 40–43, 45, 46], lung function
(n=17, ES −3.0–1.4) [22, 24–26, 30, 32, 33, 37, 39, 40, 42, 46–51], functionality (n=7, ES −1.7–6.8) [31, 40,
41, 45, 46, 52, 53], physical activity levels (n=3, ES 1.2–2.6) [26, 41, 47], vital signs and peripheral oxygen
saturation (n=10, ES −3.1–3.4) [24, 29, 31, 32, 36, 37, 39, 42, 48, 50], symptoms (n=26, ES −4.0–4.8) [20–25,
28, 29, 31–34, 36, 37, 42, 45–55], impact of disease (n=4, ES −5.1– 0.9) [30, 31, 44, 49], disease severity
(n=3, ES −4.7–−0.3) [22, 29, 31], HRQoL (n=25, ES −3.0–6.1) [18, 20–24, 26, 28–31, 33, 35, 36, 38, 39, 42,
46–48, 51, 55–58], length of stay (n=19, ES −0.8–0.9) [20, 22, 25, 26, 30, 36, 37, 40–43, 45, 46, 48, 49, 51–53,
56], new exacerbations (n=4, ES 0.1–1.0) [23, 33, 36, 38], hospital readmissions (n=14, ES 0.1–1.8) [19, 21,
22, 29, 33, 35, 38, 43, 44, 47, 52, 56–58], and mortality (n=10, ES 0.1–1.2) [18, 19, 21, 22, 37, 44, 54, 56–58].
Additionally, studies also assessed patients’ knowledge (n=4, ES −0.3–15.1) [21, 47, 56, 59], satisfaction (n=4,
ES 0.2–9.3) [47, 49, 56, 59], and self-efficacy (n=1, ES −0.2) [21]. Nine studies assessed patients’ adherence
to the intervention [18, 26, 29, 33, 35, 38–40, 44] and 16 studies explored the adverse effects associated with
the intervention [20–22, 26, 27, 29–31, 35, 40, 41, 43, 45, 48, 49, 58].
Programme designs
A huge heterogeneity was found among the design of the intervention delivered in the different studies.
Most studies were conducted in an inpatient setting (n=24) [20, 22, 25–27, 30–32, 34, 37, 40–43, 45, 46,
48–55], followed by inpatients plus patients’ home (n=6) [18, 19, 47, 57–59], hospital outpatient
departments (n=3) [28, 33, 38], patients’ home (n=3) [21, 36, 56], inpatients plus hospital outpatient
departments (n=3) [23, 24, 29], community setting (n=1) [35], and inpatients plus hospital outpatient
departments plus patients’ home (n=1) [39]. In one study [44], patients could either be treated at a
hospital outpatient department, a community setting or at home, depending on their physical status.
Studies started the intervention at a wide variety of timings, ranging from the time of admission up to
2–3 weeks after discharge. Most frequent timings to begin intervention were 24–48 h after hospital
admission (n=10) [22, 30, 31, 40, 41, 45, 46, 49, 53, 57], after hospital discharge (n=5) [28, 33, 35, 38, 56],
at the moment of hospital discharge (n=4) [18, 19, 36, 47] and at hospital admission (n=3) [25, 43, 55].
The total duration of intervention ranged from one session to 12 weeks. Frequency of sessions ranged
from two sessions per week to five sessions per day. Duration of sessions varied from <15 min to 2 h.
With regard to intervention components, 14 studies [19, 25, 27, 30, 32, 41, 45, 47, 48, 52, 54, 55, 58, 59]
used a single component in the intervention whilst the other 28 [18, 20–24, 26, 28, 29, 31, 33–40, 42–44,
46, 49–51, 53, 56, 57] applied a combination of components. Education and psychosocial support (n=24)
[18–24, 26, 28, 29, 31, 34, 35, 38, 39, 44, 46, 47, 49, 50, 56–59] was the most used component, followed by
aerobic training (n=23) [18, 21–24, 27–29, 31–41, 44, 45, 52, 53], strength training (n=23) [18, 21, 23, 24,
26, 28–31, 33–38, 40, 42–44, 46, 51, 53, 56] and breathing techniques(i.e. breathing control and/or airway
clearance techniques) (n=23) [18, 20, 22, 25, 26, 28, 30, 31, 34, 37, 39, 40, 42, 43, 48–51, 53–57]. 71%
(n=30) of the studies used exercise training as part of the intervention. Other additional components used
were electrostimulation (n=4) [27, 45, 46, 53], positive expiratory pressure therapy performed with
noninvasive ventilation [22, 54] or devices (n=3) [49], home diaries (n=2) [35, 36], respiratory muscle
training (n=1) [37], nutrition (n=1) [28] and whole body vibration (n=1) [30]. Only 16 (38.1%) of the
included studies [18, 21–24, 26, 28, 29, 31, 34, 35, 38, 39, 44, 46, 56] used pulmonary rehabilitation as an
intervention if the pulmonary rehabilitation definition is taken into account [4].
17 studies [22, 24, 26, 27, 30–33, 36, 37, 40, 41, 43–45, 49, 53] presented information about the intensity
of the intervention and, from these, seven [24, 26, 31, 37, 40, 41, 43] also described the training
progression. Exercise training was performed based on patients’ level of dyspnoea and fatigue, with
modified Borg scale scores ranging from 3 to 7 [26, 31, 36, 37, 41, 44]. Aerobic training was prescribed at
40–85% of the maximal or submaximal test result [24, 31–33, 37, 40, 44] and strength training at 40–80%
of 1-repetition maximum [24, 26, 40, 43, 44]. Additional components used were: electrostimulation, which
was applied using a range of frequencies from 12–50 Hz [27, 30, 45, 53], with 50 Hz being the most used
frequency; positive expiratory pressure therapy which was performed using 10–20 cmH2O [22, 49]; and
respiratory muscle training which was set at 50% of maximal inspiratory pressure [37].
Exercise training progressions were based on patients’ symptoms at Borg or modified Borg scale (n=5) [26,
31, 40, 41, 43] and presenting clinical condition (n=1) [37]. Increments in the aerobic training intensity
were performed by increasing the total time of aerobic exercise (n=3) [31, 40, 41], decreasing rest periods
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(n=1) [24] and increasing the velocity and workload (n=1) [41]. Strength training intensity was
incremented by increasing the resistance used (n=3) [24, 26, 40] or the number of sets (n=1) [31].
Studies defined adherence to intervention as attendance to 50–75% of sessions, which was accomplished
by 40–95% of the enrolled patients.
Intervention effects
The effects of the applied interventions on the different outcomes are summarised in table S1 and
Appendix 1.
Exercise capacity was analysed using the 6MWT. Five comparisons against control were performed (figure 2a).
The combination of exercise with breathing techniques was the intervention presenting the largest WMD
(−41.06, 95% CI −131.70–49.58), but no significant differences were found (figure 2b). The combination of
education and psychosocial support with breathing techniques was inferior to control (WMD 108.98, 95% CI
54.69–163.26) (figure 2b). Regarding the combination of exercise with breathing techniques, short-term
programmes were superior to control (WMD −63.36, 95% CI −87.67–−39.06) and presented a larger WMD
than long-term programmes (WMD −38.68, 95% CI −92.76–15.41), although the latter was not statistically
significant (figure 2c).
The modified Borg scale was used to analyse dyspnoea and four comparisons against control were
performed (figure 3a). Breathing techniques was the intervention that performed better (WMD 1.90, 95%
CI 0.53–3.27) (figure 3b). The use of education and psychosocial support alone performed worse than
control (WMD −2.78, 95% CI −4.38–−1.18) (figure 3b).
HRQoL was analysed with the SGRQ total score. Five comparisons against control were performed
(figure 4a). The combination of exercise with breathing techniques (WMD 16.07, 95% CI 10.29–21.84)
and exercise alone (WMD 13.86, 95% CI 8.36–19.36) were the interventions presenting the larger WMD
and were both superior to control (figure 4b).
Regarding to length of hospitalisation, five comparisons against control were performed (figure 5a).
Breathing techniques (ES 0.15, 95% CI −0.28–0.57) and the combination of exercise with breathing
techniques (ES 0.11, 95% CI −0.28–0.50) were the interventions presenting the larger effects, but no
significant differences were found among interventions (figure 5b).
From the 16 studies exploring the adverse effects of their interventions, only four (29%) [20, 22, 26, 40]
found any adverse events, which were mainly increased dyspnoea or oxygen desaturation. Only three
patients suffered more serious adverse events (i.e. dizziness and palpitations [22], vocal cord dysfunction [22]
and chest pain [40]), which were justified by underlying comorbidities.
Discussion
This systematic review provided a comprehensive overview on the designs of pulmonary rehabilitation
programmes implemented during AECOPD and was the first study to investigate which of those designs
are the most effective to implement during this period of the disease.
Most programmes were conducted in hospitalised patients, were started at different timings of the
AECOPD, integrated components commonly used in stable patients with COPD and were implemented
during different lengths with a wide variety of frequency, duration, intensity and progressions of sessions.
Studies started their interventions at a variety of different time points in the patient pathway, making it
difficult to establish the best time to start pulmonary rehabilitation. Early rehabilitation programmes, i.e.
programmes that were started during hospital admission or at hospital discharge, were the most
commonly used, probably because symptoms of AECOPD usually last for just 7 to 10 days [1].
The most used components in the interventions were aerobic training, strength training, breathing
techniques and education and psychosocial support, either in isolation [19, 25, 27, 30, 32, 41, 45, 47, 48,
52, 54, 55, 58, 59] or in combination [18, 20–24, 26, 28, 29, 31, 33–40, 42–44, 46, 49–51, 53, 56, 57], both
of which are also common in pulmonary rehabilitation practice with patients with stable COPD [60].
Nevertheless, during AECOPD, patients present an increased airway and systemic inflammation that
results in increased dyspnoea, cough and sputum volume and purulence, and further impairment of
muscle strength, functionality and exercise tolerance and, hence, different characteristics and needs from
those in the stable phase [1, 61, 62]. It is, therefore, likely that the core components of pulmonary
rehabilitation programmes during AECOPD will be different from those established for stable patients.
Overall pooled results showed that combining exercise with breathing techniques is the most effective
intervention to improve exercise capacity during AECOPD and the only design that results in
improvements above the minimal clinically important difference of 30 m established for the 6MWT [63],
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although this has been established for patients who are stable and not for patients with AECOPD.
Additionally, the combination of exercise with breathing techniques, followed by exercise, were the most
effective interventions to improve HRQoL, being superior to standard of care and resulting in
improvements above the minimal clinically important difference of 4 points (also established for stable
patients) in the SGRQ [64]. Breathing techniques were shown to be the most effective intervention to
reduce dyspnoea in patients with AECOPD, being superior to standard of care and resulting in
improvements above the minimal clinically important difference of 0.9 points established for the modified
Borg scale in patients with AECOPD receiving standard of care [65]. In terms of length of the
hospitalisation, breathing techniques and the combination of exercise with breathing techniques resulted in
an overall positive effect in reducing the number of days hospitalised. Furthermore, patient’s knowledge
was one of the outcome measures presenting larger ES, showing how empowering pulmonary
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FIGURE 2 Effects of the different interventions on exercise capacity measured with 6-min walk test.
a) Network plot of treatments with nodes representing the number of interventions being compared and
edges representing the available direct comparisons (comparisons evaluated in at least one study) between
pairs of interventions. b) Forest plot of network meta-analysis results (all interventions versus standard of
care). c) Forest plot of comparison of short-term programmes versus long-term programmes using a
combination of exercise with breathing techniques. WMD: weighted mean difference.
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FIGURE 4 Effects of the different interventions on health-related quality of life measured with the St George’s
respiratory questionnaire. a) Network plot of treatments with nodes representing the number of interventions
being compared and edges representing the available direct comparisons (comparisons evaluated in at least
one study) between pairs of interventions. b) Forest plot of network meta-analysis results (all interventions
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FIGURE 3 Effects of the different interventions on dyspnoea measured with the modified Borg scale.
a) Network plot of treatments with nodes representing the number of interventions being compared and
edges representing the available direct comparisons (comparisons evaluated in at least one study) between
pairs of interventions. b) Forest plot of network meta-analysis results (all interventions versus standard of
care). WMD: weighted mean difference.
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reported to health professionals [1]. Despite the short duration of these events, they have a negative impact
on patients’ health status, thus highlighting the importance of educating these patients [1]. During an
AECOPD, patients are more willing to change their behaviour and, therefore, there is a window of
opportunity for patients’ education that it is important not to miss but which should be optimised to
prevent patients’ clinical deterioration [28, 66, 67]. Based on all these findings, future studies should
consider a combination of exercise training, breathing techniques and education and psychosocial support
as core components of pulmonary rehabilitation in patients with AECOPD.
Different lengths of intervention programmes as well as different frequencies and durations of sessions
were found. Short-term programmes presented superior results to standard of care and seem to improve
exercise capacity more than programmes of longer duration. Nevertheless, these results must be
interpreted with caution as groups of studies for short- and long-term programmes presented marked
differences. Studies applying short-term programmes [22, 26, 31, 34] were all inpatient studies and thus
started their programmes earlier in the rehabilitation phase (up to the third day of hospital admission),
used daily or twice daily sessions in their interventions and were all supervised. Studies applying long-term
programmes [28, 39] started their programmes later in the rehabilitation process, only at hospital
discharge or 2 weeks after discharge, used a smaller frequency of sessions and in one of the studies most
of the sessions were not even supervised. All these aspects, together with the small number of studies and
the uncertainty about the period needed for a patient completely recover from an exacerbation [1, 62],
might have contributed to the diversity between studies and influenced the dose [68] and effectiveness of
the programmes implemented. Therefore, the most appropriate length of pulmonary rehabilitation as well
as frequency and duration of its sessions during AECOPD are yet to be determined.
Most studies lacked information about the intensity and progressions used in their interventions. It is
known that training intensity influences the physiological responses to the training and that the minimum
level of intensity to reach benefits varies due to many factors, in particular a person’s health status [68].
Therefore, studies comparing different levels of training intensities during AECOPD are needed to
establish recommendations about this aspect of the design.
Most of the available evidence published has described hospitalised patients, who are known to present
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FIGURE 5 Effects of the different interventions on length of hospitalisation measured in number of days.
a) Network plot of treatments with nodes representing the number of interventions being compared and edges
representing the available direct comparisons (comparisons evaluated in at least one study) between pairs of
interventions. b) Forest plot of network meta-analysis results (all interventions versus standard of care).
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outpatient basis [1]. Since >80% of patients with AECOPD are managed at outpatient settings [1], future
research is warranted on patients with AECOPD who are managed on an outpatient basis, i.e. in hospital
outpatient departments, community and home.
Overall, the interventions applied had few adverse effects and the three more serious events found were
related to the underlying comorbidities of the included patients [22, 40]. Thus, implementation of
pulmonary rehabilitation programmes during AECOPD seems a safe approach.
Methodological considerations
This systematic review and meta-analysis has a number of strengths and limitations that need to be
acknowledged. A thorough systematic search and screening was performed, and the most well-established
guideline for the conductance of systematic reviews (PRISMA) was followed. Additionally, the
performance of a network meta-analysis allowed the direct and indirect comparison of multiple aspects of
the design, and has been recommended as a powerful procedure that provides more precise estimates [69];
however, the framework used for the analysis is not able to include all data from trials with more than two
arms at once. Moreover, analysis of the designs of pulmonary rehabilitation programmes was found to be
highly challenging due to the large diversity of interventions, outcome measures and units of measurement
found and the lack of clarity in treatment description. All these aspects have hampered the results
synthesis and more detailed comparisons. Finally, the definition of standard care was not always clearly
described, which might have also influenced some of the pooled results.
Conclusions
Pulmonary rehabilitation is a safe intervention during AECOPD. The combination of exercise, breathing
techniques and education and psychosocial support seems to be the most effective for improvements on
dyspnoea, knowledge about the disease, exercise capacity, HRQoL and length of hospitalisation, and thus
all these components might be considered as core components to implement pulmonary rehabilitation
during AECOPD (table 2). Studies may now focus on exploring comparisons among different timings,
lengths of intervention, durations and frequencies of sessions, and intensities of exercise training to allow
the establisahment of clear recommendations regarding these aspects of the design.
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